A detailed history of Alpha Mark Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 17,539 shares of EW stock, worth $1.31 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
17,539
Previous 18,730 6.36%
Holding current value
$1.31 Million
Previous $1.73 Million 33.12%
% of portfolio
0.4%
Previous 0.6%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$59.7 - $93.78 $71,102 - $111,691
-1,191 Reduced 6.36%
17,539 $1.16 Million
Q2 2024

Jul 17, 2024

BUY
$84.3 - $94.31 $1.58 Million - $1.77 Million
18,730 New
18,730 $1.73 Million
Q3 2023

Oct 31, 2023

BUY
$69.28 - $93.38 $1.48 Million - $2 Million
21,381 New
21,381 $1.48 Million
Q1 2023

May 04, 2023

BUY
$74.26 - $84.51 $53,244 - $60,593
717 Added 2.73%
26,935 $2.23 Million
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $1.79 Million - $2.29 Million
26,218 New
26,218 $1.96 Million
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $5,190 - $7,696
60 New
60 $6,000
Q3 2021

Nov 05, 2021

SELL
$102.91 - $122.75 $6,174 - $7,365
-60 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$78.68 - $90.67 $3,934 - $4,533
-50 Reduced 45.45%
60 $5,000
Q4 2020

Feb 01, 2021

BUY
$71.69 - $91.23 $7,885 - $10,035
110 New
110 $10,000
Q2 2020

Aug 10, 2020

SELL
$57.54 - $76.95 $2,877 - $3,847
-50 Closed
0 $0
Q1 2020

Apr 24, 2020

BUY
$52.41 - $81.0 $2,620 - $4,050
50 New
50 $9,000
Q3 2019

Nov 01, 2019

SELL
$61.55 - $75.43 $2,462 - $3,017
-40 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$47.89 - $64.05 $8,141 - $10,888
-170 Reduced 80.95%
40 $8,000
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $7,193 - $8,825
155 Added 281.82%
210 $32,000
Q1 2018

May 09, 2018

BUY
$37.19 - $47.45 $2,045 - $2,609
55 New
55 $8,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.